From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
Scott Milligan, PhD
Advertisement
Articles by Scott Milligan, PhD
Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.
A statewide collaboration between payers and providers to create a cancer clinical care pathways program is successful.
Advertisement
Latest Updated Articles
- Implementation of Cancer Clinical Care Pathways
September 18th 2012
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Atacicept for IgA Nephropathy
2
340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs
3
IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk
4
Readability of Hospital Patient Financial Policy Documents
5